Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | LOX-18228 |
Synonyms | |
Therapy Description |
LOX-18228 is a next-generation RET inhibitor, potentially resulting in decreased cell growth, inhibition of tumor growth, and tumor regression (Cancer Res 2021;81(13_Suppl):Abstract nr 1464). |